Literature DB >> 1855993

Endotoxin tolerance: independent regulation of interleukin-1 and tumor necrosis factor expression.

S H Zuckerman1, G F Evans, L D Butler.   

Abstract

The injection of lethal or sublethal doses of bacterial lipopolysaccharide (LPS) into mice results in transient increases in both serum tumor necrosis factor (TNF) and interleukin-1 (IL-1). The peak in serum TNF was detected prior to maximal elevation in endogenous corticosterone and was no longer apparent 3 to 4 h post-LPS injection, a point at which corticosterone and IL-1 levels had significantly increased. The initial increase in serum IL-1 may, in part, be modulated by the preceding TNF peak, as pretreating animals with a monoclonal antibody against murine TNF resulted in a significant decrease in IL-1 levels 3 h post-LPS injection. A second injection of LPS at 20 h failed to result in a secondary TNF peak, suggesting an endotoxin-tolerant state. However, in contrast to TNF, significant increases in serum IL-1 were detected in the endotoxin-tolerant animals following a repeated LPS stimulus. This secondary increase in IL-1 occurred despite the elevation in serum corticosterone. While peritoneal macrophages from endotoxin-tolerant mice demonstrated only a modest 10 to 15% increase in TNF and IL-1 mRNA relative to the levels after the primary 1-h LPS stimulus, a secondary increase in IL-1 but not TNF mRNA in the spleen was apparent following a second LPS injection. The spleen, however, was not essential for the increase in serum IL-1, as endotoxin-tolerant splenectomized mice had comparable increases in IL-1 following a repeated LPS stimulus. These results demonstrate the differential regulation of IL-1 and TNF in vivo during endotoxin tolerance.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1855993      PMCID: PMC258086          DOI: 10.1128/iai.59.8.2774-2780.1991

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  44 in total

1.  Tolerance to the granulocyte-releasing and colony-stimulating factor elevating effects of endotoxin.

Authors:  P Quesenberry; J Halperin; M Ryan; F Stohlman
Journal:  Blood       Date:  1975-06       Impact factor: 22.113

2.  Reduced release of TNF and PCA from macrophages of tolerant mice.

Authors:  A Haslberger; T Sayers; H Reiter; J Chung; E Schütze
Journal:  Circ Shock       Date:  1988-10

3.  Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia.

Authors:  K J Tracey; Y Fong; D G Hesse; K R Manogue; A T Lee; G C Kuo; S F Lowry; A Cerami
Journal:  Nature       Date:  1987 Dec 17-23       Impact factor: 49.962

4.  Production and clearance of tumor necrosis factor in rats exposed to endotoxin and dexamethasone.

Authors:  A Waage
Journal:  Clin Immunol Immunopathol       Date:  1987-12

5.  Interleukin-1 and tumour necrosis factor mRNA expression in rheumatoid arthritis: prolonged production of IL-1 alpha.

Authors:  G Buchan; K Barrett; M Turner; D Chantry; R N Maini; M Feldmann
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

6.  Cachectin/TNF production in experimental burns and Pseudomonas infection.

Authors:  M A Marano; L L Moldawer; Y Fong; H Wei; J Minei; R Yurt; A Cerami; S F Lowry
Journal:  Arch Surg       Date:  1988-11

7.  Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression.

Authors:  S L Kunkel; M Spengler; M A May; R Spengler; J Larrick; D Remick
Journal:  J Biol Chem       Date:  1988-04-15       Impact factor: 5.157

8.  Regulation of serum tumor necrosis factor in glucocorticoid-sensitive and -resistant rodent endotoxin shock models.

Authors:  S H Zuckerman; A M Bendele
Journal:  Infect Immun       Date:  1989-10       Impact factor: 3.441

9.  Evidence for tumour necrosis factor/cachectin production in cancer.

Authors:  F Balkwill; R Osborne; F Burke; S Naylor; D Talbot; H Durbin; J Tavernier; W Fiers
Journal:  Lancet       Date:  1987-11-28       Impact factor: 79.321

10.  Regulation of tumor necrosis factor/cachectin and IL-1 secretion in human mononuclear phagocytes.

Authors:  S K Burchett; W M Weaver; J A Westall; A Larsen; S Kronheim; C B Wilson
Journal:  J Immunol       Date:  1988-05-15       Impact factor: 5.422

View more
  26 in total

1.  TLR vaccine adjuvants: closing the stable door before novel influenza strains bolt?

Authors:  Tracy Hussell; Anu Goenka
Journal:  Immunol Cell Biol       Date:  2015-11-17       Impact factor: 5.126

2.  Neuropeptide modulators of high mobility group box 1 secretion as potential therapeutic agents for severe sepsis.

Authors:  Mitchell P Fink
Journal:  Am J Pathol       Date:  2008-04-10       Impact factor: 4.307

3.  The pan-chemokine inhibitor NR58-3.14.3 abolishes tumour necrosis factor-alpha accumulation and leucocyte recruitment induced by lipopolysaccharide in vivo.

Authors:  J Reckless; L M Tatalick; D J Grainger
Journal:  Immunology       Date:  2001-06       Impact factor: 7.397

4.  Cellular adaptation to anthrax lethal toxin-induced mitochondrial cholesterol enrichment, hyperpolarization, and reactive oxygen species generation through downregulating MLN64 in macrophages.

Authors:  Soon-Duck Ha; Sangwook Park; Chae Young Han; Marilyn L Nguyen; Sung Ouk Kim
Journal:  Mol Cell Biol       Date:  2012-10-01       Impact factor: 4.272

5.  In vivo inhibition of lipopolysaccharide-induced lethality and tumor necrosis factor synthesis by Rhodobacter sphaeroides diphosphoryl lipid A is dependent on corticosterone induction.

Authors:  S H Zuckerman; N Qureshi
Journal:  Infect Immun       Date:  1992-07       Impact factor: 3.441

6.  Dynamic production of tumour necrosis factor-alpha (TNF-alpha) messenger RNA, intracellular and extracellular TNF-alpha by murine macrophages and possible association with protein tyrosine phosphorylation of STAT1 alpha and ERK2 as an early signal.

Authors:  Z M Zheng; S Specter
Journal:  Immunology       Date:  1996-04       Impact factor: 7.397

7.  Toxin-induced resistance in Bacillus anthracis lethal toxin-treated macrophages.

Authors:  Isabelle I Salles; Amy E Tucker; Daniel E Voth; Jimmy D Ballard
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-30       Impact factor: 11.205

8.  In vivo modulation of murine serum tumour necrosis factor and interleukin-6 levels during endotoxemia by oestrogen agonists and antagonists.

Authors:  S H Zuckerman; N Bryan-Poole; G F Evans; L Short; A L Glasebrook
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

9.  Attenuation of the induction of nitric oxide synthase by endogenous glucocorticoids accounts for endotoxin tolerance in vivo.

Authors:  C Szabó; C Thiemermann; C C Wu; M Perretti; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

10.  Dissociation of lipopolysaccharide (LPS)-inducible gene expression in murine macrophages pretreated with smooth LPS versus monophosphoryl lipid A.

Authors:  B E Henricson; C L Manthey; P Y Perera; T A Hamilton; S N Vogel
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.